Bees, sugar beets and a Senate that just reopened Pandora's box

One article, two molecules, one uproar

It took just one night of debate, the night of Monday June 29 into Tuesday June 30, 2026, for the French Senate to reignite a fight everyone thought was settled. By a margin of 183 votes to 129, senators approved a temporary exemption allowing the return of two insecticides banned in France, acetamiprid and flupyradifurone, as part of the emergency farm bill, according to parliamentary records from Public Sénat.

What strikes me first is the setting: a chamber tearing itself apart yet again along the same fault line, the one between the economic survival of certain farm sectors and the protection of something tiny but essential, the pollinators. This isn't a cold, technical debate. It's a societal choice being punted, once again, to a late-night vote.

Why this story hits closer to home than it seems

I'm not a farmer. I'm not a beekeeper. I've never had to choose between saving my beet harvest and protecting a wild bee. But I eat, like everyone else, and I know that whatever gets decided today in a chamber of the Palais du Luxembourg eventually ends up on my plate or in my glass of water.

That direct, almost physical link between a parliamentary decision and our most ordinary daily life is exactly what makes this piece worth writing. Not to settle the matter in place of the experts, but simply to tell what just happened.

Two molecules, four crops targeted

Concretely, the exemption passed by the Senate covers four specific crops: sugar beets, apples, cherries, and hazelnuts. For sugar beets, the text provides for a one-year exemption, renewable twice, allowing seeds to be coated with flupyradifurone, with the option of adding a curative spray of acetamiprid if the coating alone isn't enough, according to Le Monde's account of the session.

This measure falls under Article 2 quater of the emergency farm bill, adopted against the government's advice. It repeats, almost word for word, a provision from the second Duplomb law, introduced in January, which itself revived a text partially struck down the previous summer by the Constitutional Council.

The measure's loudest voice: Laurent Duplomb

Senator Laurent Duplomb, the bill's rapporteur and a beet grower himself, summed up the case for the measure with a line that lands hard: France, he argues, is the only European country to have banned these molecules for over a decade, a policy he says is "slowly killing off" French fruit production only to end up importing the same fruit grown elsewhere with the very same substances.

It's an argument with real persuasive force on paper: why hold our producers to rules their European competitors don't follow? But a convincing argument isn't automatically a fair one, and that's exactly what fuels the rest of this fight.

Numbers that make your head spin

Supporters of the measure cite precise figures to justify the urgency: the beet sector reportedly accounts for roughly 70,000 direct and indirect jobs in France, and lost, in 2025, somewhere between 30% and 75% of its production depending on the region, unable to fight viral yellowing spread by aphids without neonicotinoids. The feared long-term outcome: the closure of six sugar refineries within seven years.

These are striking numbers, almost stunning if taken at face value. But I have to be honest: at this stage I can't independently verify each of these percentages against a separate scientific source, and I'd rather say so than present them as absolute, unquestionable fact.

A land area that shows the true scale of the issue

Green senator Daniel Salmon, for his part, put forward an equally striking figure pointing the other way: roughly 400,000 hectares of beet fields could be affected by these exemptions, a considerable area that gives a real sense of the measure's actual scope, far beyond a minor, marginal exception.

That figure alone explains why environmental groups call this a "giant capitulation" rather than a minor technical adjustment: when an "exemption" covers hundreds of thousands of hectares, it stops being an exception and becomes, in effect, a policy.

A molecule Bayer has sold since 2015

Flupyradifurone has been sold in Europe since 2015 by the chemical giant Bayer, under the brand name Sivanto. It isn't technically classified as a neonicotinoid, but it shares the main characteristics of one: systemic, it attacks the central nervous system of insects, causing paralysis and then death, a fearsomely effective mechanism against crop pests.

Banned in France under a December 2019 decree, which extended the ban on neonicotinoids in effect since 2018 to molecules with a similar mode of action, flupyradifurone nonetheless holds a European authorization extended through 2029, illustrating the persistent gap between French rules and the European framework.

Wild bees, the blind spot of this debate

According to the European Food Safety Authority (EFSA), flupyradifurone's persistence in soil is rated "moderate to high," with the molecule potentially taking dozens, even hundreds of days to fully break down, carrying a high risk of groundwater contamination according to several experts, including INRAE researcher Laure Mamy.

The most troubling point concerns wild bees, nearly a thousand species recorded in France, among which the leafcutter bee was found, according to a 2022 EFSA assessment, to be "disproportionately sensitive" to this molecule. A Greek assessment, revealed by the NGO Générations Futures, even concluded there was a "high risk to bees in all relevant scenarios," with no mitigation measure, according to that report, able to bring the risk down to an acceptable level.

Words chosen to sting

Facing this reintroduction, left-wing senators didn't mince words. Daniel Salmon called it a "giant capitulation," while socialist Jean-Claude Tissot denounced "an unacceptable step backward." Fellow socialist Marion Canalès warned that the future health cost of such a decision would, in her words, be "enormous."

These aren't just ritual opposition talking points: they rest on documented concerns about the toxicity of these substances to biodiversity, and on suspicions, still scientifically debated, of endocrine-disrupting effects in humans, raised in particular by researcher Jean-Marc Bonmatin regarding a 2022 rat study.

The government itself on shaky ground

Notably, this exemption passed against the government's own recommendation. Ecological Transition Minister Monique Barbut reminded lawmakers that when serious doubts exist about a substance's effects on human health or biodiversity, the precautionary principle should apply. Agriculture Minister Annie Genevard, for her part, warned that this single article alone could "sink the entire bill," given how "explosive" the subject has become.

This split even within the executive branch says a great deal about how hard it is to settle a file where every side holds sincere, well-documented arguments that are nonetheless nearly impossible to reconcile in the short term.

A long legislative road still ahead

The emergency farm bill, which contains roughly forty articles in total, still has several steps to clear before final passage. More than 800 amendments remained to be examined at the time of the vote on the insecticides, and a joint committee of lawmakers from both chambers is scheduled for mid-July 2026 to try to find common ground between the two houses.

This tight timeline leaves little room for a calm debate: caught between legitimate farming pressure, equally legitimate environmental pushback, and an underlying electoral stake, the final text risks bearing the marks of a shaky compromise rather than a fully committed decision one way or the other.

Other equally explosive issues lying in wait

Insecticides aren't the only hot spot in this bill: water management, particularly storage infrastructure, and the question of wolf predation on livestock are also among the most contested issues, according to several outlets that have followed the Senate debates in recent days.

In other words, this piece on pesticides is just one chapter in a much larger parliamentary saga, in which French agriculture is struggling to find a balance between immediate economic competitiveness and the preservation of a living world that, itself, doesn't vote and doesn't negotiate.

Thirty thousand studies, and still no consensus

Unlike flupyradifurone, still relatively new, acetamiprid has generated a considerable body of scientific literature: roughly thirty thousand studies reportedly exist on it, compared to four thousand for its more recent cousin, according to the count cited by several specialists following the file. An impressive volume that, paradoxically, hasn't been enough to produce a clear, definitive scientific consensus on its actual level of danger to human health.

It's a classic neonicotinoid, toxic to the nervous system of insects, and suspected by part of the scientific community of having effects on biodiversity well beyond its intended target, particularly on wild and domestic pollinators that come into contact with treated crops.

The NGO Générations Futures pushes back

The organization Générations Futures is actively fighting the molecule's reauthorization, arguing that French farming competitiveness shouldn't be built on lowering health and environmental protections already in place. That position captures rather well the underlying divide between the two camps in this debate: should we race to the bottom toward Europe's most permissive standards, or push the whole continent upward instead?

This question reaches far beyond France alone: it touches on the very coherence of the European farm market, where differing rules from one country to the next inevitably create competitive distortions that each side interprets to its own advantage.

A profession that feels caught in the middle

Among beekeepers, the reaction is unambiguous: a large share of the profession does not want to see the door reopened to molecules already banned in France, fearing a new wave of mass colony deaths like the one that originally justified banning these substances in the first place.

That concern runs headlong into the worries of beet and fruit growers, who themselves face very real harvest losses and worsening economic prospects for their small operations, often far less able to absorb a bad year than large agro-industrial outfits.

The risk of piling up environmental setbacks

Several observers following the farm bill fear that this exemption, however carefully framed on paper, could open the door to a gradual pile-up of similar rollbacks on other substances or other crops, delaying the search for sustainable alternatives such as biocontrol, more resistant crop varieties, or crop rotation.

That's a substantive argument worth hearing: a one-off exemption can be justified in a genuine technical dead end, but it must never become an excuse to indefinitely delay the shift toward farming practices less dependent on synthetic chemistry.

A choice that's bigger than any of us

What this Senate vote reveals, at bottom, is our collective difficulty in choosing between two very real emergencies: that of farmers watching their sectors collapse for lack of an immediate technical alternative, and that of a tiny living creature, the pollinator, on which a good part of our future food supply depends. Neither emergency is fake. That's exactly what makes this file so uncomfortable.

I'm closing this piece without an absolute certainty to offer, and that's fine: some subjects deserve to be told honestly rather than settled with a definitive verdict handed down from behind a keyboard.

A date not to miss in mid-July

The real test will come at the joint committee meeting in mid-July, where lawmakers from both chambers will have to find common ground, or acknowledge their disagreement and let the National Assembly make the final call. Until then, beet growers, beekeepers, scientists, and advocacy groups will keep eyeing each other warily, each side sincerely convinced it's defending the public interest.

By Maxime Marquette, columnist

Editorial stance

I am not a journalist but a columnist and analyst. My expertise lies in observing and analysing the geopolitical, economic and strategic dynamics that shape our world. My work is to take political strategies apart, to understand global economic movements, to put the decisions of international actors in context and to offer analytical perspectives on the changes that are redefining our societies.

I do not claim the cold objectivity of traditional journalism, which stops at reporting facts. I claim analytical clarity, rigorous interpretation and a deep understanding of the complex issues that concern us all. My role is to give meaning to the facts, to place them in their historical and strategic context, and to offer a critical reading of events.

Method and sources

This text keeps the basic distinction between verified facts and interpretive analysis. The rule never changes: a factual claim is published only when a verifiable source supports it, and the sources this article actually used are listed under Sources, never here.

Primary source families used by the publication, when the story has them: official statements from governments and international institutions, public statements by political leaders, reports from intergovernmental organisations, dispatches from recognised international news agencies.

Secondary source families: specialised publications, internationally recognised news media, analyses from established research institutions, reports from industry organisations.

When an article cites statistical, economic or geopolitical data, it comes from the institutions that produce it (intergovernmental organisations, central banks, national statistics offices), and the exact institution is named under Sources.

Nature of the analysis

The analyses, interpretations and perspectives in the analytical sections of this article are a critical, contextual synthesis based on the information available, the trends observed and the expert comments cited in the sources consulted.

My role is to interpret these facts, to set them in the context of today's geopolitical and economic dynamics, and to give them a coherent meaning within the larger story of the changes shaping our time. These analyses reflect expertise built through continuous observation of international affairs and an understanding of the strategic mechanisms that drive global actors.

This article describes a documented state of affairs on its publication date, not a prediction: later developments may shift its outlook. No update is promised in advance; when an article is corrected or completed, the change is dated in the text.